HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ)
$33.42 0.4494 (1.363%)
Analysed HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) News Sources
TIME Names medmix as one of "World's Best Companies for Sustainable Growth 2026"
18-03-2026
yahoo.com
Medical ETF (MEDX) Touches New 52-Week High
24-02-2026
yahoo.com
Owning 41% in medmix AG (VTX:MEDX) means that insiders are heavily invested in the company's future
04-02-2026
yahoo.com
medmix (VTX:MEDX) Could Be Struggling To Allocate Capital
20-12-2025
yahoo.com
Eli Lilly Hits $1 Trillion Milestone: ETFs to Invest in
24-11-2025
yahoo.com
Horizon Kinetics Announces Upcoming Horizon Kinetics Active ETF Portfolio Manager Webinar Series
21-10-2025
yahoo.com
Is It Too Late To Consider Buying medmix AG (VTX:MEDX)?
18-10-2025
yahoo.com
A Look At The Fair Value Of medmix AG (VTX:MEDX)
17-09-2025
yahoo.com
medmix AG's (VTX:MEDX) top owners are private companies with 41% stake, while 35% is held by individual investors
27-08-2025
yahoo.com
ETFs in Focus on Eli Lilly's Solid Q2 Earnings, Weak Obesity Data
08-08-2025
yahoo.com
What is the current price of HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ)?
The current price of HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) is $33.42.
HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) absolute price change since previous trading day?
The absolute price change of HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) since the previous trading day is $0.4494.
HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) percentage price change since previous trading day?
The percentage price change of HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) since the previous trading day is 1.363%.
What is the most recent average sentiment score for HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ)?
The most recent average sentiment score for HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) is 70 out of 100.
What is the most recent average sentiment for HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ)?
The most recent sentiment for HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ) is .
SEC-8K** Filing Available For HORIZON KINETICS MEDICAL ETF (MEDX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.